{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:17:56Z","timestamp":1790421476161,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["2012\/6\/06\/A\/NZ7\/00014"],"award-info":[{"award-number":["2012\/6\/06\/A\/NZ7\/00014"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.neuropharm.2016.06.025","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T10:45:28Z","timestamp":1469529928000},"page":"149-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Neurochemical and behavioral studies on the 5-HT 1A -dependent antipsychotic action of the mGlu 4 receptor agonist LSP4-2022"],"prefix":"10.1016","volume":"115","author":[{"given":"Monika","family":"Wo\u017aniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Go\u0142embiowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Noworyta-Soko\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Acher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Cie\u015blik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Tokarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Pilc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Wiero\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.neuropharm.2016.06.025_bib1","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1021\/jm970207b","article-title":"Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes","volume":"40","author":"Acher","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.06.025_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0028-3908(03)00304-6","article-title":"Regulation by 5-HT1A receptors of the in\u00a0vivo release of 5-HT and DA in mouse frontal cortex","volume":"45","author":"Ago","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.06.025_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2012.05.026","article-title":"Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease","volume":"66","author":"Amalric","year":"2013","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.025_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cercor\/bhg128","article-title":"Co-expression and in\u00a0vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex","volume":"14","author":"Amarg\u00f3s-Bosch","year":"2004","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(90)90473-J","article-title":"A\u00a0single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism","volume":"178","author":"Beer","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.025_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1096-9861(20000214)417:3<263::AID-CNE1>3.0.CO;2-H","article-title":"Immunocytochemical localization of the metabotropic glutamate receptor mGluR4a in the piriform cortex of the rat","volume":"417","author":"Ben\u00edtez","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"10","key":"10.1016\/j.neuropharm.2016.06.025_bib7","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1096\/fj.09-131789","article-title":"Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism","volume":"23","author":"Beurrier","year":"2009","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.06.025_bib8","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1523\/JNEUROSCI.16-06-02044.1996","article-title":"Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies","volume":"16","author":"Bradley","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9861(19990428)407:1<33::AID-CNE3>3.0.CO;2-G","article-title":"Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia","volume":"407","author":"Bradley","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuropharm.2006.11.004","article-title":"The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801","volume":"52","author":"Buben\u00edkov\u00e1-Valesov\u00e1","year":"2007","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.025_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-008-1205-9","article-title":"The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotoninrelease evoked by MK-801 in mice prefrontal cortex","volume":"200","author":"Castane","year":"2008","journal-title":"Psychopharmacol. Berl."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-8993(91)90748-K","article-title":"Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain\u2013a combined in situ hybridisation\/in\u00a0vitro receptor autoradiographic study","volume":"561","author":"Chalmers","year":"1991","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.06.025_bib13","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.3390\/ijms160818474","article-title":"Functional selectivity and antidepressant activity of serotonin 1A receptor ligands","volume":"16","author":"Chilmonczyk","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1300.002","article-title":"Physiological roles and therapeutic potential of metabotropic glutamate receptors","volume":"1003","author":"Conn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.06.025_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0026-895X(25)11082-1","article-title":"Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase","volume":"39","author":"Cornfield","year":"1991","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.06.025_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.pnpbp.2008.04.013","article-title":"The putative antipsychotic alstonine reverses social interaction withdrawal in mice","volume":"32","author":"de Moura Linck","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0091-3057(98)00128-2","article-title":"Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex","volume":"61","author":"Etou","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-4328(96)00118-0","article-title":"Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist","volume":"73","author":"Fletcher","year":"1996","journal-title":"Behav. Brain. Res"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bcp.2012.04.013","article-title":"Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs","volume":"84","author":"Flor","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.06.025_bib22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00702-008-0174-9","article-title":"Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia","volume":"116","author":"Fuxe","year":"2009","journal-title":"J.\u00a0Neural Transm."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.06.025_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12640-012-9316-9","article-title":"The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2","volume":"22","author":"Golembiowska","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib25","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1096\/fj.11-195941","article-title":"A\u00a0novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential","volume":"26","author":"Goudet","year":"2012","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.06.025_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00179315","article-title":"The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in\u00a0vivo","volume":"338","author":"Hjorth","year":"1988","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib80","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0024-3205(91)90216-X","article-title":"Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in\u00a0vivo microdialysis","volume":"48","author":"Hjorth","year":"1991","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","article-title":"A\u00a0neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)","volume":"205","author":"Howes","year":"2014","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2016.06.025_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.npp.1300313","article-title":"Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor\/glycine-site agonists","volume":"29","author":"Javitt","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.025_bib32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0022-3565(25)38872-5","article-title":"Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei","volume":"269","author":"Kreiss","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.06.025_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.59.7.663","article-title":"Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia","volume":"59","author":"Krystal","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2016.06.025_bib35","first-page":"222","article-title":"Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice","volume":"578","author":"Leite","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ddstr.2006.10.018","article-title":"Metabotropic glutamate receptor targets for neuropsychiatric disorders","volume":"3","author":"Linden","year":"2006","journal-title":"Drug Discov. Today Ther. Strateg."},{"issue":"10","key":"10.1016\/j.neuropharm.2016.06.025_bib37","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.npp.1301356","article-title":"Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat","volume":"32","author":"Lopez-Gil","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1017\/S1461145708009267","article-title":"Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action","volume":"12","author":"Lopez-Gil","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib39","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1152\/jn.1985.54.4.782","article-title":"Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex","volume":"54","author":"McCormick","year":"1985","journal-title":"J.\u00a0Neurophysiol."},{"issue":"10","key":"10.1016\/j.neuropharm.2016.06.025_bib40","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s11064-014-1415-y","article-title":"Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential","volume":"39","author":"Mercier","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1300.065","article-title":"Glutamatergic animal models of schizophrenia","volume":"1003","author":"Moghaddam","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2007.07.019","article-title":"Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice","volume":"149","author":"Nilsson","year":"2007","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.neuropharm.2016.06.025_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2174\/1568026054750254","article-title":"New therapeutic frontiers for metabotropic glutamate receptors","volume":"5","author":"Niswender","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jep.2013.01.032","article-title":"Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice","volume":"146","author":"Oh","year":"2013","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00441-005-1112-x","article-title":"5-HT1A receptor expression in pyramidal neurons of cortical and limbic brain regions","volume":"321","author":"Palchaudhuri","year":"2005","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2008.06.033","article-title":"Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents","volume":"55","author":"Palucha-Poniewiera","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.06.025_bib48","series-title":"The Rat Brain in Stereotoxic Coordinates","author":"Paxinos","year":"2007"},{"issue":"12","key":"10.1016\/j.neuropharm.2016.06.025_bib49","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","article-title":"Glutamate-based antidepressants: preclinical psychopharmacology","volume":"73","author":"Pilc","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.06.025_bib51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neuropharm.2015.05.039","article-title":"A\u00a0novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action","volume":"97","author":"Podkowa","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.106.110809","volume":"321","author":"Rorick-Kehn","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2016.06.025_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(93)90994-S","article-title":"Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in\u00a0vivo microdialysis study","volume":"239","author":"Routledge","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.06.025_bib54","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjp.0703139","article-title":"Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in\u00a0vivo dopamine release in rat prefrontal cortex","volume":"129","author":"Sakaue","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1124\/jpet.109.151118","article-title":"Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one","volume":"330","author":"Satow","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2016.06.025_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0270(90)90045-H","article-title":"Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor","volume":"34","author":"Sharp","year":"1990","journal-title":"J.\u00a0Neurosci. Methods"},{"issue":"19","key":"10.1016\/j.neuropharm.2016.06.025_bib58","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997","article-title":"Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus","volume":"17","author":"Shigemoto","year":"1997","journal-title":"J.\u00a0Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.06.025_bib59","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/bph.12254","article-title":"The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents","volume":"169","author":"Slawinska","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.06.025_bib60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0893-133X(00)00150-0","article-title":"WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801","volume":"23","author":"Wedzony","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.025_bib61","first-page":"229","article-title":"A\u00a0search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices -immunohistochemical studies","volume":"59","author":"Wedzony","year":"2008","journal-title":"J.\u00a0Physiol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2016.06.025_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuint.2009.02.019","article-title":"Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs","volume":"55","author":"Wieronska","year":"2009","journal-title":"Neurochem. Int."},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2016.06.025_bib63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuropharm.2010.08.008","article-title":"Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems","volume":"59","author":"Wieronska","year":"2010","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.025_bib64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-011-2502-2","article-title":"Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia","volume":"220","author":"Wieronska","year":"2012","journal-title":"Psychopharmacol. Berl."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.025_bib65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00213-013-3005-0","article-title":"The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT\u2081A signalling","volume":"227","author":"Wieronska","year":"2013","journal-title":"Psychopharmacol. Berl."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-014-3657-4","article-title":"The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies","volume":"232","author":"Wieronska","year":"2015","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2013.08.007","article-title":"The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu\u2082\/\u2083 receptor agonist, LY379268, is 5-HT\u2081A dependent","volume":"256","author":"Wiero\u0144ska","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.06.025_bib69","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1570159X13666150516000630","article-title":"The involvement of GABAB signaling in the antipsychotic-like action of the novel orthosteric agonist of mGlu4 receptor, LSP4\u2013202","volume":"14","author":"Wozniak","year":"2016","journal-title":"Curr. Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(97)01435-0","article-title":"Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex","volume":"341","author":"Yonezawa","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.025_bib71","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/jpet.106.107490","article-title":"Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor activation","volume":"320","author":"Zhang","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"19","key":"10.1016\/j.neuropharm.2016.06.025_bib72","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.lfs.2005.09.022","article-title":"Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior","volume":"78","author":"Zuo","year":"2006","journal-title":"Life Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:01:55Z","timestamp":1749013315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816302787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":70,"alternative-id":["S0028390816302787"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}